AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Comparing Merck and AbbVie: A Detailed Look
August 22, 2024 06:03 PM AEST| By Team Kalkine MediaHeadlines,Merck Outpaces AbbVie in Revenue Growth,Merck's Superior Profitability and Stability in Pharma,Merck,(NYSE:MRK),has shown strong gains, with its stock price increasing by 65% from early 2021 to around $115 today. However, AbbVie has outperf...
Eli Lilly's Strong Q2 Performance: What's Ahead?
August 15, 2024 01:40 AM AEST| By Team Kalkine MediaHeadlines,Solid Q2 Results: Eli Lilly surpassed expectations with $11.3 billion in revenue and adjusted earnings of $3.92 per share, prompting a 15% rise in its stock price.,Exceptional Performance: The stock has seen a 455% increase since January 20...
2 Biotech Companies to Monitor in August 2024
August 15, 2024 01:10 AM AEST| By Team Kalkine MediaHeadlines,The biotech sector focuses on innovative medical treatments using biological processes, offering substantial growth if successful.,Biotech companies, like Regeneron and Vertex Pharmaceuticals, work on developing drugs and therapies for seri...
Carlyle Group to Acquire Baxter's Kidney-Care Unit Vantive for $3.8 Billion
August 14, 2024 12:40 AM AEST| By Team Kalkine MediaCarlyle Group (NASDAQ:CG),has agreed to purchase Baxter International's kidney-care unit, Vantive, for $3.8 billion. The acquisition, announced on Tuesday, is part of Baxter's strategy to reduce its substantial debt and streamline operations followin...
Novo Nordisk Faces Triple Setback: What Does This Mean for Its Future?
August 13, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Novo Nordisk has encountered three significant challenges recently, affecting its research and regulatory submissions.,The company halted a clinical trial for a MASH treatment, received regulatory pushback on its type 1 diabetes therapy, an...
Anteris Technologies Pursues Nasdaq Listing and US IPO Through Re-Domiciliation
August 13, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Anteris Technologies is planning to relocate its headquarters to the US and relist on the Nasdaq, with a secondary listing on the ASX and an initial public offering (IPO) aimed at raising between US$75 million and US$100 million by the end...
Cardinal Health’s Q4 Earnings Preview: What to Expect and How to Optimize Dividend Returns
August 12, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Cardinal Health is expected to release its Q4 earnings on August 14, with anticipated growth in earnings per share and revenue.,The company has a dividend yield of 2.01%, providing regular payouts to shareholders.,The number of shares neede...
Eli Lilly vs. Johnson & Johnson: Two Pharma and Healthcare Stocks with Global Reach
August 09, 2024 09:48 PM AEST| By Team Kalkine MediaEli Lilly (NYSE:LLY),and,Johnson & Johnson (NYSE:JNJ),are two of the most prominent players in the pharmaceutical and healthcare industries. Both companies are renowned for their extensive product portfolios and global reach, but they are navigating...
Why Eli Lilly's Stock Dropped 20% Last Month
August 09, 2024 02:28 AM AEST| By Team Kalkine MediaHeadlines,Eli Lilly's stock fell 20% in July after Roche announced positive clinical trial results for a weight loss drug.,The competitive landscape in obesity treatments is intensifying, potentially impacting Lilly's market share.,Despite its curren...
CVS Health Struggles with Medicare Business, Cuts Earnings Forecast and Announces Major Cost-Cutting Plan
August 08, 2024 02:09 AM AEST| By Team Kalkine MediaCVS Health (NYSE:CVS) reported continued difficulties in its Medicare business for the second quarter, leading to another reduction in its full-year earnings outlook. The company also unveiled a $2 billion cost-cutting initiative and announced the de...
Bayer's Second-Quarter Loss Misses Expectations Amid Agricultural Market Challenges
August 07, 2024 12:00 AM AEST| By Team Kalkine MediaBayer AG (BAYRY), the German pharmaceutical and agricultural giant, reported a significant net loss for the second quarter, falling short of analysts' expectations due to a challenging agricultural market. The company posted a net loss of €34 million...
Can Recursion Pharmaceuticals Lead to Wealth Creation?
August 06, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Current Status and Pipeline:,Recursion Pharmaceuticals is a young biotech firm with a market cap of $2.2 billion and no marketed products. It relies on collaborations for revenue and has several clinical programs in its pipeline, including...
Top 9 Health Care Stocks Making Waves in August 2024
August 05, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Top Contenders:,Discover the nine standout health care stocks from the,S&P 500,, showcasing their impressive performance over the past year.,Health Care Sectors Explored:,Dive into the different health care sectors, including biotechnology,...
Avidity Biosciences Grants Stock Options and RSUs to New Chief Legal Officer
August 05, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Avidity Biosciences announced stock option and RSU grants to John B. Moriarty, Jr. as part of his hiring package.,The awards were granted under the 2022 Employment Inducement Incentive Award Plan in compliance with Nasdaq Listing Rule 5635(...
TransMedics Sees Stock Price Surge After Impressive Earnings Report
August 03, 2024 12:27 AM AEST| By Team Kalkine MediaHeadlnes,TransMedics reports a 118% revenue increase for Q2 2024, surpassing expectations.,The company raised its full-year 2024 revenue outlook, indicating significant growth.,Expansion of logistics services and plans for new clinical programs drive...
Is Merck a Strong Bet After Q2 Performance?
August 03, 2024 12:18 AM AEST| By Team Kalkine MediaHeadlines,Merck’s Q2 results exceeded revenue and earnings estimates.,Keytruda sales drove growth, but Gardasil faced shipment issues.,Stock is trading near estimated value, with an uncertain future outlook.,Merck,(NYSE:MRK),recently reported its Q2...
Pfizer’s Bold $43 Billion Move: Is It Paying Off?
August 02, 2024 05:00 PM AEST| By Team Kalkine MediaHeadlines,Pfizer's acquisition of Seagen aims to boost its oncology portfolio significantly.,Seagen’s products show promise in capturing market share and driving revenue growth.,The oncology drug market's expected expansion aligns with Pfizer’s long-...
Vaccinex stock tanks 40% despite positive Alzheimer’s study update
August 01, 2024 01:21 AM AEST| By InvezzVaccinex Inc (NASDAQ: VCNX) tanked an alarming 40% on Wednesday despite it reporting positive early-stage results for its Alzheimer’s treatment. The biotechnology company said its SIGNAL-AD trial established its pepinemab antibody as well-tolerated b...
Why is Inari Medical Making Headlines Today
July 31, 2024 11:06 PM AEST| By Team Kalkine MediaInari Medical (,NARI,), a company specializing in minimally invasive solutions for venous and vascular diseases, released its second-quarter financial results on July 30. The company achieved notable revenue growth but also faced significant increase...
Tenet Healthcare (NYSE:THC) Jumps 18 Spots on Barchart’s Top 100
July 31, 2024 09:30 PM AEST| By Team Kalkine MediaTenet Healthcare,(NYSE:THC),leaped 18 places in Barchart’s Top 100 list, now ranked 67th with a weighted alpha of 119.97, surpassing its impressive 106% return over the last year. When the weighted alpha exceeds the 52-week return, it suggests that t...
